Fig. 3
From: FOXD3 may be a new cellular target biomarker as a hypermethylation gene in human ovarian cancer
FOXD3 methylated analysis of tumor tissues and normal tissues. a FOXD3 was differentially methylated in tumor tissues compared to paired normal tissues. b The top 20 candidate genes methylation degree were analyzed, FOXD3 was found to be hypermethylated in tumor tissues compared to paired normal tissues. c–f Boxplots of methylation data for 4 of the top differentially methylated imprinted sites in the ovarian cancer tumor vs. surrounding comparison (n = 10 tumor/surrounding pairs): c cg 10097295, d cg 18279094, e cg 21836358 and f cg 22815110